Identification and validation of CDK1 as a promising therapeutic target for Eriocitrin in colorectal cancer: a combined bioinformatics and experimental approach
Abstract Background Colorectal cancer (CRC) is a prevalent malignancy worldwide, associated with significant morbidity and mortality. Cyclin-dependent kinase 1 (CDK1) plays a crucial role in cell cycle regulation and has been implicated in various cancers. This study aimed to evaluate the prognostic...
Saved in:
Main Authors: | Jiemiao Shen, Xing Gong, Haili Ren, Xia Tang, Hairong Yu, Yilu Tang, Shen Chen, Minghui Ji |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-025-13448-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Experience with CDK4/6 Inhibitors in the First-Line Palliative Setting for HR+/HER2− Advanced Breast Cancer
by: Ram Patel, et al.
Published: (2025-01-01) -
Ribociclib-induced vitiligo in a case of metastatic carcinoma of the breast
by: Abhira Deb, et al.
Published: (2025-01-01) -
High expression of SHP2 predicts a promising prognosis in colorectal cancer
by: Xibo Liu, et al.
Published: (2023-07-01) -
Prognostic significance of p27 in colorectal cancer: a meta-analysis and bioinformatics analysis
by: Jing Zou, et al.
Published: (2024-12-01) -
Ki-67 and CDK1 control the dynamic association of nuclear lipids with mitotic chromosomes
by: Hsiao-Tang Hu, et al.
Published: (2025-01-01)